Researchers race to develop Paxlovid replacement
Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.
16 hours ago
0
1